What will be funded?
Two standalone CGMs will be funded. You will be able to choose either of these CGM devices:
The Dexcom One+
The FreeStyle Libre 2
Abbott and NZMS would supply standalone reader devices free of charge, to people who do not have a smartphone or smart device compatible with their respective CGMs.
If you qualify for a funded insulin pump you can get a funded CGM that is compatible with your pump.
Tandem T slim works with:
Dexcom G6
Dexcom G7
The Tandem t:slim X2 will also work with the FreeStyle Libre 3 Plus by July 2025
The mylife Ypso Pump will work with:
Dexcom G6
FreeStyle Libre 3 +
How many CGMs do I get?
The maximum number of devices varies by product because they work in different ways.
The following maximum funded sensors per patient per year applies:
FreeStyle Libre 2
up to 29 devices will be funded each year
Up to 7 devices on each prescription.
Dexcom One Plus
up to 40 devices will be funded each year
Up to 9 devices on each prescription.
FreeStyle Libre 3 Plus
Up to 28 devices will be funded each year.
Up to 7 devices on each prescription.
Dexcom G6
Up to 5 packs will be funded each year.
Up to 1 pack on each prescription.
Each pack contains 1 transmitter and 9 sensors
Dexcom G7
Up to 40 devices will be funded each year.
Up to 9 devices on each prescription.
Note: funding will not include the cost of GP visits and you will pay a co-payment (usually $5) at the pharmacy if you do not qualify for free prescriptions.
How long will I receive funding for?
Initial applications are valid for 1 year. Renewal approvals are valid for 2 years where the patient is continuing to derive benefit according to the treatment plan agreed at induction.
What accessories are funded?
Adhesive over-patches will be supplied with all of the Dexcom devices. Adhesive patches are not needed for the FreeStyle Libre devices.
The suppliers will provide a standalone reader device to people who do not have a compatible smartphone that they can operate the relevant application on.